rxstat › Classes › Antiinflammatory/antirheumatic Prod.,non-steroids
Antiinflammatory/antirheumatic Prod.,non-steroids: shortage status in Canada
10 of the 16 antiinflammatory/antirheumatic prod.,non-steroids rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageEsomeprazole Naproxen2 of 3 reported products affected · est. return Nov 24, 2026Widespread shortageTiaprofenic Acid2 of 4 reported products affectedPartial shortageCelecoxib1 of 31 reported products affectedPartial shortageDiclofenac2 of 7 reported products affected · est. return Jul 24, 2026Partial shortageIbuprofen2 of 14 reported products affected · est. return Jul 3, 2026Partial shortageIndomethacin3 of 7 reported products affected · est. return Oct 10, 2026Partial shortageMefenamic Acid1 of 2 reported products affected · est. return Jul 17, 2026Partial shortageNaproxen7 of 29 reported products affected · est. return Aug 21, 2026Partial shortageNaproxen1 of 8 reported products affected · est. return Dec 25, 2024Partial shortageOxaprozin1 of 1 reported products affectedDiscontinuedEtodolac0 of 2 reported products affectedDiscontinuedKetoprofen0 of 6 reported products affectedNo current shortageMisoprostol DiclofenacNo current shortagePiroxicamNo current shortageSulindacDiscontinuedTenoxicam0 of 1 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.